Investigational Drug Details
| Drug ID: | D421 |
| Drug Name: | N,N,N-trimethylglycinium |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB04455 |
| DrugBank Description: | A naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1341) |
| PubChem ID: | 248 |
| CasNo: | |
| Repositioning for NAFLD: | Yes |
| SMILES: | C[N+](C)(C)CC(O)=O |
| Structure: |
|
| InChiKey: | KWIUHFFTVRNATP-UHFFFAOYSA-O |
| Molecular Weight: | 118.1543 |
| DrugBank Targets: | Circadian clock protein KaiB; Glycine betaine-binding periplasmic protein |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|